DCGI has allowed the Serum Institute of India to conduct phase 2 and 3 human clinical trials in India on the potential COVID19 vaccine.
from Latest News https://www.dnaindia.com/india/report-coronavirus-vaccine-dcgi-gives-nod-to-serum-oxford-for-phase-2-3-clinical-trials-in-india-2835633
Sunday, August 2, 2020
Home »
Latest News
,
News
» Coronavirus vaccine: DCGI gives nod to Serum-Oxford for phase 2, 3 clinical trials in India






0 comments:
Post a Comment